In ₹ Crore except Per Share Latest Annual | AGARWALEYE FY26 | AKUMS FY26 | ADVENZYMES FY26 | ALIVUS FY24 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | 118.81× | 44.99× | ◆ 20.04× | — | 32.52× +265% | |
| P/B | 7.48× | 3.45× | ◆ 2.01× | — | 2.73× +174% | |
| EV/EBITDA | 27.67× | 21.40× | ◆ 11.83× | — | 16.61× +67% | |
| Market Cap | ₹15,846 Cr | ₹11,483 Cr | ₹3,382 Cr | — | ₹7,433 Cr +113% | |
| Growth | ||||||
| Revenue CAGR 3Y | — | — | 11.32% | — | 11.32% | |
| Revenue CAGR 5Y | — | — | 8.24% | — | 8.24% | |
| Net Income CAGR 3Y | — | — | 18.68% | — | 18.68% | |
| Revenue YoY (latest Q) | ◆ 25.97% | 13.93% | 2.08% | — | 8.00% +224% | |
| Net Income YoY (latest Q) | 44.56% | ◆ 56.11% | -4.58% | — | 25.77% +73% | |
| Profitability | ||||||
| EBITDA Margin | 27.38% | 11.98% | ◆ 30.72% | 29.53% | 29.53% -7% | |
| Net Income Margin | 8.08% | 5.88% | ◆ 23.28% | 20.62% | 20.62% -61% | |
| Return on Common Equity | 6.28% | 7.66% | 10.02% | ◆ 20.19% | 10.02% -37% | |
| Return on Capital Employed | 8.43% | 8.44% | 10.91% | ◆ 25.74% | 10.91% -23% | |
| Return on Assets | 4.27% | 4.71% | 9.44% | ◆ 16.52% | 9.44% -55% | |
| Credit & Quality | ||||||
| Total Debt/Equity | 0.07× | 0.02× | ◆ 0.01× | — | 0.01× +367% | |
| Interest Coverage | 3.24× | 3.91× | 71.91× | ◆ 401.55× | 71.91× -95% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹2,080 Cr | ₹4,359 Cr | ₹746 Cr | ₹2,283 Cr | ₹2,283 Cr -9% | |
| Net Income | ₹168 Cr | ₹256 Cr | ₹174 Cr | ₹471 Cr | ₹256 Cr -34% | |
| Total Assets | ₹3,942 Cr | ₹5,447 Cr | ₹1,839 Cr | ₹2,850 Cr | ₹2,850 Cr +38% | |
| EPS | ₹4.21 | ₹16.67 | ₹15.08 | — | ₹15.88 -73% | |
| Book Value per Share | ₹66.91 | ₹217.57 | ₹150.38 | — | ₹183.98 -64% | |